COSMOS Pharmaceutical Dividends and Buybacks
Dividend criteria checks 0/6
COSMOS Pharmaceutical is a dividend paying company with a current yield of 1%. Next payment date is on 13th February, 2025 with an ex-dividend date of 28th November, 2024.
Key information
1.0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 1.2% |
| Dividend Growth | 11.0% |
| Next dividend pay date | 13 Feb 25 |
| Ex dividend date | 28 Nov 24 |
| Dividend per share | JP¥65.000 |
| Payout ratio | 18% |
Recent dividend and buyback updates
Recent updates
COSMOS Pharmaceutical's (TSE:3349) Returns On Capital Not Reflecting Well On The Business
Nov 18
We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Sep 26An Intrinsic Calculation For COSMOS Pharmaceutical Corporation (TSE:3349) Suggests It's 41% Undervalued
Aug 17COSMOS Pharmaceutical (TSE:3349) Will Want To Turn Around Its Return Trends
Aug 01Subdued Growth No Barrier To COSMOS Pharmaceutical Corporation's (TSE:3349) Price
Jun 28We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Jun 10COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 17Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio
Mar 16Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture
Feb 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 3349 is not paying a notable dividend for the JP market, therefore no need to check if payments are stable.
Growing Dividend: 3349 is not paying a notable dividend for the JP market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| COSMOS Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (3349) | 1.0% |
| Market Bottom 25% (JP) | 1.8% |
| Market Top 25% (JP) | 3.8% |
| Industry Average (Consumer Retailing) | 1.6% |
| Analyst forecast (3349) (up to 3 years) | 1.2% |
Notable Dividend: 3349's dividend (1%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.83%).
High Dividend: 3349's dividend (1%) is low compared to the top 25% of dividend payers in the JP market (3.84%).
Earnings Payout to Shareholders
Earnings Coverage: 3349 is not paying a notable dividend for the JP market.
Cash Payout to Shareholders
Cash Flow Coverage: 3349 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 09:14 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
COSMOS Pharmaceutical Corporation is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arashi Nishizawa | BofA Global Research |
| Mitsuru Takayanagi | Citigroup Inc |
| Jun Kawahara | Daiwa Securities Co. Ltd. |